Excedrin (brand)

Last updated
A bottle of Excedrin with some of the caplets Excedrin Migraine.jpg
A bottle of Excedrin with some of the caplets

Excedrin is an over-the-counter headache pain reliever, typically in the form of tablets or caplets. It contains paracetamol (acetaminophen), aspirin, and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other products from BMS's over-the-counter business. As of March 2015, GSK holds majority ownership of Excedrin through a joint venture transaction with Novartis. [1] On 18 July 2022, GSK spun off its consumer healthcare business (including Excedrin) to Haleon.

Contents

The brand became known for advertisements where it cured especially unpleasant and excruciating headaches (called "Excedrin headaches" in the ads of 1970s, [2] and later called "Excedrin tension headaches"). In 2007, the brand branched out into marketing for other types of pains with the introduction of Excedrin Back & Body, without caffeine.

Excedrin is mentioned in Stephen King's 1977 novel The Shining , as a headache remedy for Jack Torrance. [3]

Principles of work

Excedrin is a combination medication composed of acetaminophen, aspirin, and caffeine. These medications treat migraine headache in a variety of ways.

Acetaminophen is a fever reducer and painkiller. Its precise mechanism is unknown. It is known that it mostly affects the brain and spinal cord, which are parts of the central nervous system. By lowering the quantity of prostaglandins the body produces, acetaminophen raises the threshold for pain.

Aspirin is a nonsteroidal anti-inflammatory drug (NSAID). It lessens irritation and swelling as well as discomfort and inflammation. The amount of prostaglandins the body produces is also decreased by aspirin, but not in the same way that acetaminophen does.

Caffeine acts as a vasoconstrictor, [4] causing blood vessels to become smaller. This helps to restrict the blood vessels in the brain. As a result, the amount of blood that may pass through the blood arteries at once is reduced. There are several theories regarding the cause and exacerbation of headaches, and it is thought by some that vasodilation may contribute to symptoms. [5] If a headache is brought on by caffeine withdrawal, the caffeine content of Excedrin may relieve it. [4]

Versions

An Excedrin magazine ad in Persian, Zan-e Rooz weekly, 16 January, 1971 Excedrin - Magazine ad - Zan-e Rooz, Issue 303 - 16 January 1971.jpg
An Excedrin magazine ad in Persian, Zan-e Rooz weekly, 16 January, 1971

Over the years, different forms of the drug have been introduced: [6] [7]

Canada

Excedrin is no longer sold in Canada. [12]

Previously, Excedrin Migraine and Excedrin Extra Strength sold in Canada had a different formulation compared to the US. In Canada the product sold with those names contained 500 mg of acetaminophen and 65 mg of caffeine per tablet. The reason was that the combination of acetaminophen with aspirin creates the risk of renal papillary necrosis if large doses are taken chronically.

Ownership

In 2005, Bristol-Myers Squibb announced the sale of its North American consumer medicine business (including Excedrin, Comtrex and Keri brands) to Novartis for $660 million, in order to focus on drugs for the ten most profitable disease areas. [13] As of March 2015, GlaxoSmithKline held majority ownership through a joint venture transaction with Novartis. [1]

Recall and production stoppage

2012 recall

On January 9, 2012, Novartis announced that it was voluntarily recalling all lots of select bottle-packaging configurations of Excedrin products with expiration dates of December 20, 2014, or earlier as a precautionary measure because the products may contain stray tablets, capsules, or caplets from other Novartis products, or contain broken or chipped tablets. The recall was conducted with the knowledge of the U.S. Food and Drug Administration. [14] Wholesalers and retailers were instructed to stop distribution and return the affected product. Consumers in possession of recalled Excedrin were instructed to stop using the product and contact Novartis. Novartis stated that Excedrin would be shipping to stores on October 15, 2012, and that customers would start seeing it by the first of November. [15]

January 2020 production stoppage

On January 21, 2020, GlaxoSmithKline announced that production and distribution of caplets and gel tabs of Excedrin Extra Strength and Excedrin Migraine would be stopped temporarily. Their statement said, "Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients" for the recalled products, and that production would restart "shortly". [16] [17] However, GSK acknowledged that they "cannot confirm a definite date as to when supply will resume". [18]

December 2020 recall

On December 26, 2020 The U.S. Consumer Product Safety Commission announced the recall of 400,000 bottles of Excedrin due to the containers of the drug allegedly having holes in the bottom. The concern behind the recall was that the plastic bottles, if they had a hole, could allow children to access the painkiller caplets and lead to dangerous overdose or poisoning. [19] [20] The recall involved bottles containing 50, 80, 100, 152, 200, 250, or 300 caplets. [21]

See also

Related Research Articles

<span class="mw-page-title-main">Paracetamol</span> Common medication for pain and fever

Paracetamol is a non-opioid analgesic and antipyretic agent used to treat fever and mild to moderate pain. It is a widely used over the counter medication. Common brand names include Tylenol and Panadol.

<span class="mw-page-title-main">Tylenol (brand)</span> Medication

Tylenol is a brand of medication, advertised for reducing pain, reducing fever, and relieving the symptoms of allergies, cold, cough, headache, and influenza. The active ingredient of its original flagship product is paracetamol, an analgesic and antipyretic. Like the words paracetamol and acetaminophen, the brand name Tylenol is derived from a chemical name for the compound, N-acetyl-para-aminophenol (APAP). The brand name is owned by McNeil Consumer Healthcare, a subsidiary of Kenvue.

Oxycodone/aspirin is a combination drug marketed by Endo Pharmaceuticals. It is a tablet containing a mixture of 325 mg of aspirin and 4.8355 mg of oxycodone HCl ; it is an opioid/non-opioid combination used to treat moderate to moderately severe pain. The safety of the combination during pregnancy has not been established, although aspirin is generally contraindicated during pregnancy, and the drug has been placed in pregnancy category D. Inactive ingredients include D&C Yellow 10, FD&C Yellow 6, microcrystalline cellulose, and corn starch. Percodan was first marketed by DuPont Pharmaceuticals and prescribed in the United States in 1950. Once a widely prescribed painkiller, it has largely been replaced by alternative oxycodone compounds containing paracetamol (acetaminophen) instead of aspirin, such as Percocet.

<span class="mw-page-title-main">Dihydrocodeine</span> Opioid

Dihydrocodeine is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with paracetamol (acetaminophen) or aspirin. It was developed in Germany in 1908 and first marketed in 1911.

Maalox was a brand of antacid owned by Sanofi. Their main product is a flavored liquid containing a suspension of aluminum hydroxide and magnesium hydroxide, which act to neutralize or reduce stomach acid, for the purpose of relieving the symptoms of indigestion, heartburn, gastroesophageal reflux disease, and also stomach or duodenal ulcers. It also contains simethicone, an anti-foaming agent which helps eliminate bloating from gas. In large doses, the medicine can act as a laxative. The trademark is owned by Novartis International AG, and was first produced commercially in 1949.

<span class="mw-page-title-main">Butalbital</span> Barbiturate drug used for headaches

Butalbital is a barbiturate with an intermediate duration of action. Butalbital is often combined with other medications, such as paracetamol (acetaminophen) or aspirin, for the treatment of pain and headache. The various formulations combined with codeine are FDA-approved for the treatment of tension headaches. Butalbital has the same chemical formula as talbutal but a different structure—one that presents as 5-allyl-5-isobutylbarbituric acid.

BC Powder is an American brand of over-the-counter analgesic pain reliever owned by Prestige Consumer Healthcare and manufactured in Washington, DC.

Goody's Powder, also called Goody's Headache Powders, is an over-the-counter aspirin/paracetamol/caffeine–based pain reliever, in single-dose powder form, which is marketed and sold by Prestige Brands. The powder delivery saves the time needed for the patient's digestive system to break down a tablet or capsule, ostensibly causing the medication to work faster. Goody's Extra Strength Powder consists of aspirin, caffeine, and paracetamol (acetaminophen) in a formula identical to that of Excedrin, a product of Novartis, but in the no-digestion-needed powder form.

<span class="mw-page-title-main">Anacin</span> Analgesic brand

Anacin is an American brand of analgesic that is manufactured by Prestige Consumer Healthcare. Its product contains aspirin and caffeine.

Propyphenazone/paracetamol/caffeine is an analgesic combination indicated for the management of headache. It contains the analgesics propyphenazone and paracetamol and the stimulant caffeine.

Stella Maudine Nickell is an American woman who was sentenced to ninety years in prison for product tampering after she poisoned Excedrin capsules with lethal cyanide, resulting in the deaths of her husband Bruce Nickell and Sue Snow, a stranger. Her May 1988 conviction and prison sentence were the first under federal product tampering laws instituted after the 1982 Chicago Tylenol murders.

<span class="mw-page-title-main">Salicylamide</span> Chemical compound

Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedy PainAid. It was also an ingredient in the over-the-counter pain remedy BC Powder but was removed from the formulation in 2009, and Excedrin used the ingredient from 1960 to 1980 in conjunction with aspirin, acetaminophen, and caffeine. It was used in later formulations of Vincent's powders in Australia as a substitute for phenacetin.

A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form. Terms like "combination drug" or "combination drug product" can be common shorthand for an FDC product, although the latter is more precise if in fact referring to a mass-produced product having a predetermined combination of drugs and respective dosages. And it should also be distinguished from the term "combination product" in medical contexts, which without further specification can refer to products that combine different types of medical products—such as device/drug combinations as opposed to drug/drug combinations. When a combination drug product is a "pill", then it may also be a kind of "polypill" or combopill.

<span class="mw-page-title-main">Hydrocodone/paracetamol</span> Combination pain relief drug

Hydrocodone/paracetamol is the combination of the pain medications hydrocodone and paracetamol (acetaminophen). It is used to treat moderate to severe pain. It is taken by mouth. Recreational use is common in the United States.

<span class="mw-page-title-main">Codeine</span> Opiate and prodrug of morphine used to treat pain

Codeine is an opiate and prodrug of morphine mainly used to treat pain, coughing, and diarrhea. It is also commonly used as a recreational drug. It is found naturally in the sap of the opium poppy, Papaver somniferum. It is typically used to treat mild to moderate degrees of pain. Greater benefit may occur when combined with paracetamol (acetaminophen) or a nonsteroidal anti-inflammatory drug (NSAID) such as aspirin or ibuprofen. Evidence does not support its use for acute cough suppression in children or adults. In Europe, it is not recommended as a cough medicine in those under 12 years of age. It is generally taken by mouth. It typically starts working after half an hour, with maximum effect at two hours. Its effects last for about four to six hours. Codeine exhibits abuse potential similar to other opioid medications, including a risk of habituation and overdose.

Encaprin was a brand of safety-coated aspirin capsules made by Procter & Gamble in the mid-1980s through its Norwich Eaton Pharmaceuticals division. In 1986, the brand was involved in a cyanide poisoning hoax, and its sales never recovered.

<span class="mw-page-title-main">Hydrocodone/ibuprofen</span> Combination drug

Hydrocodone/ibuprofen (INNs), sold under the brand name Vicoprofen, is a fixed-dose combination analgesic medication used in short-term therapy to relieve severe pain. Vicoprofen combines the analgesic and antitussive properties of hydrocodone with the analgesic, anti-inflammatory, and antipyretic properties of ibuprofen. In contrast to hydrocodone/acetaminophen combination analgesics such as Vicodin, this hydrocodone/ibuprofen avoids some of the liver toxicity which may occur from acetaminophen, but still presents significant dangers in hydrocodone overdose, namely respiratory depression. Vicoprofen is supplied in a fixed dose combination tablet which contains hydrocodone bitartrate, USP 7.5 mg with ibuprofen, USP 200 mg. Additional strengths of generic Vicoprofen are now available, in combinations of 5 mg/200 mg and 10 mg/200 mg respectively.

Aspirin/paracetamol/caffeine is a combination drug for the treatment of pain, especially tension headache and migraine. It contains aspirin, a non-steroidal anti-inflammatory drug; paracetamol (acetaminophen), an analgesic; and caffeine, a stimulant.

Nurofen is a brand name range of pain-relief medication containing ibuprofen made by the British multinational Reckitt. Introduced in 1983, the Nurofen brand was acquired following Reckitt Benckiser's acquisition of Boots healthcare international in 2005 for £1.93 billion, which included Nurofen, Strepsils, and Clearasil. The brand is primarily marketed and sold in the United Kingdom, other parts of Europe, South Africa, Australia and New Zealand. In 2016 it was the biggest selling branded over-the-counter medication sold in Great Britain, with sales of £116.8 million.

References

  1. 1 2 "GSK/Novartis Transaction". Archived from the original on 2016-12-18. Retrieved 2016-12-15.
  2. ↑ Excedrin Headache Commercial (1976) , retrieved 2022-09-19
  3. ↑ King, S.(1977) The Shining. 2007 edn. London: Hodder and Stoughton
  4. 1 2 Phillip R. Slavney; Orest Hurko (28 March 2001). The Primary Care Physician's Guide to Common Psychiatric and Neurologic Problems: Advice on Evaluation and Treatment from Johns Hopkins. JHU Press. pp. 188–. ISBN   978-0-8018-6554-1.
  5. ↑ "How a Migraine Happens". www.hopkinsmedicine.org. 2019-11-26. Retrieved 2023-08-20.
  6. ↑ "Relief for Tension Headache Pain – Bristol-Myers Squibb Launches Excedrin(R) Tension Headache". BMS News. June 2003.
  7. ↑ "Excedrin.com > Product Guide". Nov 12, 2006. Archived from the original on November 10, 2006. Retrieved November 12, 2006.
  8. ↑ "Bristol-Myers Squibb Announces Injectable Acetaminophen Licencing Agreement – Agreement Expands Existing Pain Management Portfolio". BMS News. January 28, 2002.
  9. 1 2 "New Headache Relief – No Water Needed". Bristol-Myers Squibb. October 7, 2002.[ permanent dead link ]
  10. ↑ "Bristol-Myers Squibb News". Bristol-Myers Squibb. Archived from the original on 2007-05-20. Retrieved 2007-05-08.
  11. ↑ "Excedrin Back & Body". Excedrin.com. Archived from the original on 2007-05-19. Retrieved 2007-05-08.
  12. ↑ "Health Canada". Archived from the original on 2022-11-16. Retrieved 2022-10-16.
  13. ↑ "Novartis swallows Excedrin". Daily Record. April 15, 2005.
  14. ↑ "Excedrin Recall". FDA.gov. January 9, 2012.
  15. ↑ Voight, Joan (September 4, 2012). "Excedrin and Tylenol Suffer Recall Headache". Adweek.
  16. ↑ White, Dawson (January 21, 2020). "Excedrin is temporarily stopping production of two drugs meant to treat migraines". Miami Herald. Retrieved January 23, 2020.
  17. ↑ Grumman Bender, Rachel (January 22, 2020). "What migraine sufferers need to know about Excedrin as production is halted". Yahoo Lifestyle. Retrieved January 23, 2020.
  18. ↑ Karimi, Faith (January 22, 2020). "Two Excedrin products are temporarily discontinued, company says". CNN. Retrieved January 23, 2020.
  19. ↑ "Excedrin recalls more than 400k bottles of popular headache, migraine painkillers". Fox 59. 2020-12-26. Retrieved 2021-06-03.
  20. ↑ "Excedrin Recall: What You Need to Know". Migraine Again. 2021-02-18. Retrieved 2021-06-03.
  21. ↑ "Excedrin recalls more than 400k bottles of popular headache, migraine painkillers". WKRG News 5. 2020-12-25. Retrieved 2021-06-03.
  22. ↑ "Tylenol Terrorist". Crime Library. Archived from the original on 2005-06-24. Retrieved 2005-11-13.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.